Report makes the case for new TB vaccines
Investing more financial resources to accelerate scientific progress toward an effective tuberculosis vaccine will save lives, fight antimicrobial resistance, advance health equity, improve economic growth, and bring a substantial return on investment, according to a new report.
Is new malaria vaccine ‘world-changing’? Maybe.
Harvard Chan School's Dyann Wirth offers some thoughts on a new malaria vaccine and its potential impact.
Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy
For immediate release: September 1, 2022 Boston, MA— Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by…
A better antibiotic for tuberculosis treatment
PhD candidate Harim Won is developing a new type of antibiotic to address long-standing issues of lengthy treatments and drug resistance, using a new approach to turn a normal protein system in the bacterial cell against itself.
‘The infectious disease that nobody ever thinks about’
To mark World TB Day, March 24, Harvard Chan School's Sarah Fortune, a TB expert, discusses the state of the disease worldwide, obstacles to fighting it, and the latest research.
Threat of antibiotic resistance looms large
While COVID-19 has garnered significant attention from the public and media, antibiotic resistance is a slow-moving threat to global health that is often overlooked even though the World Health Organization estimates that antibiotic-resistant infections could kill as many…
Climate in the clinic
Physicians, health leaders discuss how to address the health impacts of climate change February 19, 2020 – Climate change—and how it affects health—should be front and center for doctors, health care workers, and hospitals. That was the key…
Excessive rates of antibiotic prescriptions for children in low- and middle-income countries
For immediate release: Friday, December 13, 2019 Boston, MA – Children in low- and middle-income countries (LMICs) are receiving an average of 25 antibiotic prescriptions during their first five years of life, an excessive amount that could harm the…
Nonprescription antibiotic use a cause for concern
Some people in the U.S. are using antibiotics without a prescription, a trend that could increase the threat of drug resistance, according to new research. The study defined nonprescription antibiotic use as obtaining, storing, taking or intending to…
Antibiotic helps prevent childhood deaths, but raises concerns of drug resistance
Mass administration of the antibiotic azithromycin to children between the ages of 1 and 9 in Ethiopia significantly reduced deaths when compared with children that weren’t given the antibiotic, according to new research. The drug was administered to…